A meeting of the Advisory Committee on Medicines Scheduling (ACMS).
Members
The committee members are professionals with specific scientific, medical or clinical expertise, or expertise in consumer health issues relating to medicines.
Pre-meeting notice
For the pre-meeting public consultation notice go to:
Outcomes
-
Scheduling submissionsPublic submissions on matters referred to the July 2017 scheduling meetings, and received during the pre-meeting and interim decision consultation periods, are now available
-
Scheduling decisions (final)Final decisions and reasons for matters referred to ACCS#20, ACMS #21 (July 2017 meetings) and Joint ACCS-ACMS #15 and #16 (March and July 2017meetings).
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 3 October 2017